banner

News

Mar 14, 2023
Category: Pipac
Posted by: pipac

IMPORTANT NEWS FOR OR-NURSES

Feb 28, 2023
Category: Pipac
Posted by: pipac

Registration is open.

Jun 22, 2022
Category: Pipac
Posted by: pipac

The date for the next PIPAC Workshop is 8-9 Juni, 2023


PIPAC Publications

Publications

    1. Khosrawipour T, Khosrawipour V, Giger-Pabst U. Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma. PLoS One. 2017 Oct 19;12(10):e0186709. doi: 10.1371/journal.pone.0186709. eCollection 2017. PubMed PMID: 29049340.
    2. Hilal Z, Rezniczek GA, Klenke R, Dogan A, Tempfer CB. Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis. J Gynecol Oncol. 2017 Nov;28(6):e80. doi: 10.3802/jgo.2017.28.e80. PubMed PMID: 29027398; PubMed Central PMCID: PMC5641530.
    3. Alyami M, Gagniere J, Sgarbura O, Cabelguenne D, Villeneuve L, Pezet D, Quenet F, Glehen O, Bakrin N, Passot G. Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis. Eur J Surg Oncol. 2017 Sep 21. pii: S0748-7983(17)30700-X. doi: 10.1016/j.ejso.2017.09.010. PubMed PMID: 28964609.
    4. Cazauran JB, Alyami M, Lasseur A, Gybels I, Glehen O, Bakrin N. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video). J Gastrointest Surg. 2017 Sep 12. doi: 10.1007/s11605-017-3565-0. [Epub ahead of print] PubMed PMID: 28900843.
    5. Fournier P, Allemann P, Hubner M, Halkic N, Schäfer M, Demartines N. Novelties in surgery in 2016. Rev Med Suisse. 2017 Jan 11;13(544-545):33-36. French. PubMed PMID: 28703532.
    6. Bellendorf A, Khosrawipour V, Khosrawipour T, Siebigteroth S, Cohnen J, Diaz-Carballo D, Bockisch A, Zieren J, Giger-Pabst U. Scintigraphic peritoneography reveals a non-uniform (99m)Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model. Surg Endosc. 2017 Jun 22. doi: 10.1007/s00464-017-5652-4. PubMed PMID: 28643076. 
    7. Sleeman JP. PIPAC puts pressure on peritoneal metastases from pancreatic cancer. Clin Exp Metastasis. 2017 Jun 7. doi: 10.1007/s10585-017-9851-0. PubMed PMID: 28593512. 
    8. Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. 2017 May 17. doi: 10.1007/s10585-017-9849-7. [Epub ahead of print] PubMed PMID: 28516306.  
    9. Khosrawipour V, Diaz-Carballo D, Acikelli AH, Khosrawipour T, Falkenstein TA, Wu D, Zieren J, Giger-Pabst U. Erratum to: Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2017 May 2;15(1):94. doi: 10.1186/s12957-017-1155-y. PubMed PMID: 28464940;
    10. Hübner M, Grass F, Teixeira-Farinha H, Pache B, Mathevet P, Demartines N. Pressurized IntraPeritoneal Aerosol Chemotherapy - Practical aspects. Eur J Surg Oncol. 2017 Jun;43(6):1102-1109. doi: 10.1016/j.ejso.2017.03.019. Epub 2017 Apr 8. PubMed PMID: 28431896.
    11. Grass F, Vuagniaux A, Teixeira-Farinha H, Lehmann K, Demartines N, Hübner M. Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis. Br J Surg. 2017 May;104(6):669-678. doi: 10.1002/bjs.10521. Review. PubMed PMID: 28407227.  
    12. Khosrawipour V, Khosrawipour T, Hedayat-Pour Y, Diaz-Carballo D, Bellendorf A, Böse-Ribeiro H, Mücke R, Mohanaraja N, Adamietz IA, Fakhrian K. Effect of Whole-abdominal Irradiation on Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in a Post-mortem Swine Model. Anticancer Res. 2017 Apr;37(4):1677-1680. PubMed PMID: 28373428. 
    13. Hübner M, Teixeira Farinha H, Grass F, Wolfer A, Mathevet P, Hahnloser D, Demartines N. Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study. Gastroenterol Res Pract. 2017;2017:6852749. doi: 10.1155/2017/6852749. Epub 2017 Feb 26. PubMed PMID: 28331493; PubMed Central PMCID: PMC5346367. 
    14. Teixeira Farinha H, Grass F, Kefleyesus A, Achtari C, Romain B, Montemurro M, Demartines N, Hübner M. Impact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study. Gastroenterol Res Pract. 2017;2017:4596176. doi: 10.1155/2017/4596176. Epub 2017 Feb 21. PubMed PMID: 28316621; PubMed Central PMCID: PMC5339484. 
    15. Khosrawipour V, Diaz-Carballo D, Acikelli AH, Khosrawipour T, Falkenstein TA, Wu D, Zieren J, Giger-Pabst U. Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells. World J Surg Oncol. 2017 Feb 10;15(1):43. doi: 10.1186/s12957-017-1109-4. Erratum in: World J Surg Oncol. 2017 May 2;15(1):94. Ali-Haydar, Acikelli [corrected to Acikelli, Ali-Haydar]. PubMed PMID: 28183319; PubMed Central PMCID: PMC5301439.  
    16. empfer CB, Hartmann F, Hilal Z, Rezniczek GA. Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report. BMC Cancer. 2017 Jan 6;17(1):26. doi: 10.1186/s12885-016-3004-8. PubMed PMID: 28061769; PubMed Central PMCID: PMC5216537. 
    17. Girshally R, Demtröder C, Albayrak N, Zieren J, Tempfer C, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2016 Sep 27;14(1):253. PubMed PMID: 27678344; PubMed Central PMCID: PMC5039790.
    18. Göhler D, Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Falkenstein TA, Zieren J, Stintz M, Giger-Pabst U. Technical description of the microinjection pump (MIP(®)) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC). Surg Endosc. 2017 Apr;31(4):1778-1784. doi: 10.1007/s00464-016-5174-5. Epub 2016 Sep 8. PubMed PMID: 27631320. 
    19. Khosrawipour V, Khosrawipour T, Falkenstein TA, Diaz-Carballo D, Förster E, Osma A, Adamietz IA, Zieren J, Fakhrian K. Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model. Anticancer Res. 2016 Sep;36(9):4595-600. PubMed PMID: 27630300. 
    20. Khosrawipour V, Khosrawipour T, Kern AJ, Osma A, Kabakci B, Diaz-Carballo D, Förster E, Zieren J, Fakhrian K. Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model. J Cancer Res Clin Oncol. 2016 Nov;142(11):2275-80. doi: 10.1007/s00432-016-2234-0. Epub 2016 Sep 2. PubMed PMID: 27590613. 
    21. Khosrawipour V, Bellendorf A, Khosrawipour C, Hedayat-Pour Y, Diaz-Carballo D, Förster E, Mücke R, Kabakci B, Adamietz IA, Fakhrian K. Irradiation Does Not Increase the Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model. In Vivo. 2016 09-10;30(5):593-7. PubMed PMID: 27566077.  
    22. Rezniczek GA, Jüngst F, Jütte H, Tannapfel A, Hilal Z, Hefler LA, Reymond MA, Tempfer CB. Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer. BMC Cancer. 2016 Aug 19;16:654. doi: 10.1186/s12885-016-2668-4. PubMed PMID: 27542596; PubMed Central PMCID: PMC4992274. 
    23. Khosrawipour V, Giger-Pabst U, Khosrawipour T, Pour YH, Diaz-Carballo D, Förster E, Böse-Ribeiro H, Adamietz IA, Zieren J, Fakhrian K. Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model. J Cancer. 2016 May 7;7(8):910-4. doi: 10.7150/jca.14714. eCollection 2016. PubMed PMID: 27313780; PubMed Central PMCID: PMC4910582. 
    24. Graversen M, Pfeiffer P, Mortensen MB. Treatment of peritoneal carcinomatosis with pressurized intraperitoneal aerosol chemotherapy. Ugeskr Laeger. 2016 May 23;178(21). pii: V11150928. Danish. PubMed PMID: 27237925. 
    25. Robella M, Vaira M, De Simone M. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis. World J Surg Oncol. 2016 Apr 29;14:128. doi: 10.1186/s12957-016-0892-7. PubMed PMID: 27125996; PubMed Central PMCID: PMC4850728. 
    26. Roulin D, Hübner M, Allemann P, Demartines N. New developments of surgery in 2015. Rev Med Suisse. 2016 Jan 13;12(500):23-5. French. PubMed PMID: 26946697.
    27. Kakchekeeva T, Demtröder C, Herath NI, Griffiths D, Torkington J, Solaß W, Dutreix M, Reymond MA. In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC). Ann Surg Oncol. 2016 Dec;23(Suppl 5):592-598. Epub 2016 Feb 2. PubMed PMID: 26842487; PubMed Central PMCID: PMC5149560. 
    28. Jung do H, Son SY, Oo AM, Park YS, Shin DJ, Ahn SH, Park do J, Kim HH. Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model. Surg Endosc. 2016 Oct;30(10):4258-64. doi: 10.1007/s00464-015-4738-0. Epub 2015 Dec 29. PubMed PMID: 26715024. 
    29. Tempfer CB, Rezniczek GA, Ende P, Solass W, Reymond MA. Pressurized Intraperitoneal Aerosol Chemotherapy with Cisplatin and Doxorubicin in Women with Peritoneal Carcinomatosis: A Cohort Study. Anticancer Res. 2015 Dec;35(12):6723-9. PubMed PMID: 26637888. 
    30. Khosrawipour V, Khosrawipour T, Diaz-Carballo D, Förster E, Zieren J, Giger-Pabst U. Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Ann Surg Oncol. 2016 Apr;23(4):1220-4. doi: 10.1245/s10434-015-4954-9. Epub 2015 Nov 9. PubMed PMID: 26553440.
    31. Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis. J Gastrointest Surg. 2016 Feb;20(2):367-73. doi: 10.1007/s11605-015-2995-9. Epub 2015 Oct 28. PubMed PMID: 26511950; PubMed Central PMCID: PMC4722080.
    32. Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis. 2016 Apr;18(4):364-71. doi: 10.1111/codi.13130. PubMed PMID: 26400556.
    33. Tempfer CB. Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. Med Hypotheses. 2015 Oct;85(4):480-4. doi: 10.1016/j.mehy.2015.07.001. Epub 2015 Jul 29. PubMed PMID: 26277656.
    34. Hübner M, Teixeira H, Boussaha T, Cachemaille M, Lehmann K, Demartines N. PIPAC--Pressurized intraperitoneal aerosol chemotherapy. A novel treatment for peritoneal carcinomatosis. Rev Med Suisse. 2015 Jun 17;11(479):1325-30. French. PubMed PMID: 26255492. 
    35. Odendahl K, Solass W, Demtröder C, Giger-Pabst U, Zieren J, Tempfer C, Reymond MA. Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Eur J Surg Oncol. 2015 Oct;41(10):1379-85. doi: 10.1016/j.ejso.2015.06.001. Epub 2015 Jun 21. PubMed PMID: 26138283.
    36. Tempfer CB, Solass W, Buerkle B, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report. Gynecol Oncol Rep. 2014 Oct 18;10:32-5. doi: 10.1016/j.gore.2014.10.001. eCollection 2014 Dec. PubMed PMID: 26076000; PubMed Central PMCID: PMC4434151. 
    37. Giger-Pabst U, Solass W, Buerkle B, Reymond MA, Tempfer CB. Low-dose pressurized intraperitoneal aerosol chemotherapy (PIPAC) as an alternative therapy for ovarian cancer in an octogenarian patient. Anticancer Res. 2015 Apr;35(4):2309-14. PubMed PMID: 25862894.  
    38. Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger-Pabst U, Zieren J, Rezniczek GA, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study. Gynecol Oncol. 2015 May;137(2):223-8. doi: 10.1016/j.ygyno.2015.02.009. Epub 2015 Feb 18. PubMed PMID: 25701703.
    39. Sabaila A, Fauconnier A, Huchon C. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): a new way of administration in peritoneal carcinomatosis of ovarian cancer. Gynecol Obstet Fertil. 2015 Jan;43(1):66-7. doi: 10.1016/j.gyobfe.2014.11.012. Epub 2014 Dec 15. French. PubMed PMID: 25523545. 
    40. Tempfer CB, Solass W, Reymond MA. Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review. Wien Med Wochenschr. 2014 Dec;164(23-24):519-28. doi: 10.1007/s10354-014-0312-y. Epub 2014 Sep 24. Review. PubMed PMID: 25249025.
    41. Oyais A, Solass W, Zieren J, Reymond MA, Giger-Pabst U. Occupational Health Aspects of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC): Confirmation of Harmlessness. Zentralbl Chir. 2016 Aug;141(4):421-4. doi: 10.1055/s-0033-1350909. Epub 2014 Feb 4. German. PubMed PMID: 24497166.
    42. Tempfer CB, Celik I, Solass W, Buerkle B, Pabst UG, Zieren J, Strumberg D, Reymond MA. Activity of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with cisplatin and doxorubicin in women with recurrent, platinum-resistant ovarian cancer: preliminary clinical experience. Gynecol Oncol. 2014 Feb;132(2):307-11. doi: 10.1016/j.ygyno.2013.11.022. Epub 2013 Nov 23. PubMed PMID: 24275155. 
    43. Solass W, Kerb R, Mürdter T, Giger-Pabst U, Strumberg D, Tempfer C, Zieren J, Schwab M, Reymond MA. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014 Feb;21(2):553-9. doi: 10.1245/s10434-013-3213-1. Epub 2013 Sep 5. PubMed PMID: 24006094; PubMed Central PMCID: PMC3929768.
    44. Solass W, Giger-Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013 Oct;20(11):3504-11. doi: 10.1245/s10434-013-3039-x. Epub 2013 Jun 14. PubMed PMID: 23765417; PubMed Central PMCID: PMC3764316.  
    45. Blanco A, Giger-Pabst U, Solass W, Zieren J, Reymond MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2013 Jul;20(7):2311-6. doi: 10.1245/s10434-012-2840-2. Epub 2013 Feb 3. PubMed PMID: 23377563; PubMed Central PMCID: PMC3675273.
    46. Graversen M, Mortensen MB. Environmental safety during the administration of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Pleura and Peritoneum 2016; 1(4): 203–208
    47. Graversen M, Detlefsen S, Bjerregaard JK, Pfeiffer P, Mortensen MB. Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC). Clin Exp Metastasis. 2017 May 17. doi: 10.1007/s10585-017-9849-7
    48. Graversen M, Mortensen MB. PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY (PIPAC): A new treatment modality in patients with peritoneal metastases from pancreatic cancer? Pancreatic cancer, nordic newsletter, no. 4, 2017. (Invited publication)
    49. Graversen M. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Portuguese Digestive Cancer Congress Journal. (Invited publication)
    50. Solanki SL, Kumar PP, DeSouza A, Saklani AP. Perioperative concerns and management of pressurised intraperitoneal aerosolised chemotherapy: Report of two cases. Indian J Anaesth. 2018 Mar;62(3):225-228. doi: 10.4103/ija.IJA_623_17. PMID:29643558
    51. Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, Ceelen W, Reymond M, Pezet D, Arvieux C, Khomyakov V, Lay L, Gianni S, Zegarski W, Bakrin N, Glehen O. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Eur J Surg Oncol. 2018 Feb 22. pii: S0748-7983(18)30674-7. doi: 10.1016/j.ejso.2018.02.014. [Epub ahead of print]. PMID:29526367
    52. Dueckelmann AM, Fink D, Harter P, Heinzelmann V, Marth C, Mueller M, Reinthaller A, Tamussino K, Wimberger P, Sehouli J. Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO Switzerland. Arch Gynecol Obstet. 2018 Apr;297(4):847. doi: 10.1007/s00404-018-4715-7. PMID: 29445924
    53. Dueckelmann AM, Fink D, Harter P, Heinzelmann V, Marth C, Mueller M, Reinthaller A, Tamussino K, Wimberger P, Sehouli J. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)", the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology. Arch Gynecol Obstet. 2018 Apr;297(4):837-846. doi: 10.1007/s00404-018-4673-0. Epub 2018 Jan 22. Review. Erratum in: Arch Gynecol Obstet. 2018 Feb 14;:. PMID: 29356953
    54. Göhler D, Große S, Bellendorf A, Falkenstein TA, Ouaissi M, Zieren J, Stintz M, Giger-Pabst U. Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept. Beilstein J Nanotechnol. 2017 Dec 18;8:2729-2740. doi: 10.3762/bjnano.8.272. eCollection 2017. PMID: 29354344
    55. Seitenfus R, Ferreira PRW, Santos GOD, Alves RJV, Kalil AN, Barros ED, Glehen O, Casagrande TAC, Bonin EA, Silva Junior EMD. A prototype single-port device for pressurized intraperitoneal aerosol chemotherapy. Technical feasibility and local drug distribution. Acta Cir Bras. 2017 Dec;32(12):1056-1063. doi: 10.1590/s0102-865020170120000007. PMID: 29319734
    56. Teixeira Farinha H, Grass F, Labgaa I, Pache B, Demartines N, Hübner M. Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy. J Cancer. 2018 Jan 1;9(1):13-20. doi: 10.7150/jca.21460. eCollection 2018. PMID: 29290765
    57. Falkenstein TA, Götze TO, Ouaissi M, Tempfer CB, Giger-Pabst U, Demtröder C. First Clinical Data of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as Salvage Therapy for Peritoneal Metastatic Biliary Tract Cancer. Anticancer Res. 2018 Jan;38(1):373-378. PMID: 29277797
    58. Nowacki M, Peterson M, Kloskowski T, McCabe E, Guiral DC, Polom K, Pietkun K, Zegarska B, Pokrywczynska M, Drewa T, Roviello F, Medina EA, Habib SL, Zegarski W. Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis. Oncotarget. 2017 Aug 31;8(44):78208-78224. doi: 10.18632/oncotarget.20596. eCollection 2017 Sep 29. Review.
    59. Mortensen MB, Glehen O, Horvath P, Hübner M, Hyung-Ho K, Königsrainer A, Pocard M, Reymond MA, So J, Fristrup CW. The ISSPP PIPAC database: design, process, access, and first interim analysis. Pleura and Peritoneum 2021 (1-7) doi.org/10.1515/pp-2021-0108 

 

 

Oral Presentations:

  1. Implementation and evaluation of PIPAC for the treatment of patients with peritoneal carcinomatosis. DKS Årsmøde 2016, København
  2. Implementation and evaluation of PIPAC, 3rd International PIPAC symposium, 2016, Baltimore, USA. Invited speaker.
  3. The PIPAC Procedure, First Scandinavian PIPAC Symposium 2017, Odense, Danmark
  4. Implementing PIPAC, First Scandinavian PIPAC Symposium 2017, Odense, Danmark
  5. Treating before Seeing, First Scandinavian PIPAC Symposium 2017, Odense, Danmark
  6. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) som palliativ behandling ved pancreascancer med peritoneal karcinose. Dansk Pancreas Forum 2017, København
  7. Occupational health safety in PIPAC, 4th International PIPAC Symposium 2017, Tübingen, Tyskland. Invited speaker.
  8. Peritoneal Sclerosis after PIPAC, 4th International PIPAC Symposium 2017, Tübingen, Tyskland. Invited speaker.
  9. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). 13. Portuguese Digestive Cancer Congress 2017. Invited speaker.
  10. Peritoneal metastases from pancreatic cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). Scandinavian HPB meeting, Lund, Sverige 2017.
  11. Behandling af carcinose med PIPAC. Øvre gastointestinal cancer – seminar 2017. Invited speaker.

 

 

 

 

 

 

 

 

 

 



OUH